Immunosuppressants Market by Drug Class and Geography - Forecast and Analysis 2022-2026

The immunosuppressants market share is expected to increase to USD 6.99 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.73%.

This immunosuppressants market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers immunosuppressants market segmentations by drug class (corticosteroids, monoclonal antibodies, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The immunosuppressants market report also offers information on several market vendors, including AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc. among others.

What will the Immunosuppressants Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Immunosuppressants Market Size for the Forecast Period and Other Important Statistics

Immunosuppressants stop your immune system from damaging healthy cells and tissues. People with organ transplants and stem cell transplants take these medicines to prevent transplant rejections. Some of these drugs are used to make the body less likely to reject a transplanted organ, such as a liver, heart, or kidney. These drugs are also called as antirejection drugs. Other immunosuppressant drugs are often used to treat autoimmune disorders such as lupus, psoriasis, and rheumatoid arthritis.

Who are the Major Immunosuppressants Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• AbbVie Inc.
• Accord Healthcare Ltd.
• Astellas Pharma Inc.
• Belcher Pharmaceuticals LLC
• Bristol Myers Squibb Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Intas Pharmaceuticals Ltd.
• Johnson and Johnson
• LEO Pharma AS
• Livzon Pharmaceutical Group Inc.
• Novartis AG
• Pfizer Inc.
• RPG Life Sciences Ltd.
• Sanofi
• Sebela Pharmaceuticals Inc.
• TFF Pharmaceuticals Inc.
• Viatris Inc.

 

This statistical study of the immunosuppressants market encompasses successful business strategies deployed by the key vendors. The immunosuppressants market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Immunosuppressants Market: Key Drivers, Trends, and Challenges

The reimbursement policies for kidney transplantation is notably driving the immunosuppressants market growth, although factors such as side effects of immunosuppressants may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the immunosuppressants industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Immunosuppressants Market Driver

• The reimbursement policies for kidney transplantation is one of the key drivers supporting the immunosuppressants market growth.
• Chronic kidney disease (CKD) affects more than 25 million Americans every year. It causes a greater number of deaths than prostate cancer or breast cancer, and a large percentage of individuals (85%) with CKD remain unaware of their condition.
• Considering the rising burden of CKD in the US, public organizations such as the National Kidney Foundation are making efforts by collaborating with the US National Congress and various other organizations to recognize organ transplantation as a top priority.
• At present, Medicare coverage provides insurance for 36 months after the transplantation and extending this insurance coverage for immunosuppressive drugs for a lifetime for those who undergo kidney transplantation is important. Many patients living in economically backward countries, may find it challenging to afford the costs associated with immunosuppressive therapy. However, patient assistance programs make drugs affordable for patients. Such initiatives are driving the immunosuppressants market growth. 

Key Immunosuppressants Market Trend

• High dependency on immunosuppressants for kidney transplantation is one of the key immunosuppressant market trends contributing to market growth.
• The immune system recognizes the transplanted kidney as a foreign organ and triggers a blood transfusion reaction, which leads to transplant rejection.
• Transplant rejection is a major challenge faced by patients who have undergone transplantation. However, to overcome this challenge, immunosuppressants are developed.
• Patients are required to undergo maintenance therapy using these immunosuppressants for the rest of their lives to reduce the risk and probability of the transplanted organ getting rejected by the body.
• There are increasing cases of kidney transplantation and the risks associated with transplant rejection, which will increase the demand for immunosuppressants. This, in turn, will propel the market growth.

Key Immunosuppressants Market Challenge

• Side effects of immunosuppressants is one of the factors hampering the immunosuppressants market growth.
• Though the use of immunosuppressants is highly effective in reducing the risk of organ rejection. However, it is known to be associated with multiple side effects.
• The side effects of immunosuppressants are often mild, and they include diarrhea, increased risk of various infections, nausea, and vomiting. However, since these side effects often last for a long time, they significantly affect the patient's adherence to the treatment using these drugs.
• Immunosuppressants are known to cause significant damage to muscles, which can lead to a decrease in muscle function. These drugs are also known to cause side effects such as hyperglycemia, which is a condition that results in an increased blood sugar level, and secondary diabetes.
• If not treated on time, the side effects often get worse and cause significant morbidity in the patients. Although these severe side effects are rare in most patients, they often lead to low patient adherence to immunosuppressants. Such factors may hinder the immunosuppressants market growth during the forecast period.

This immunosuppressants market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global immunosuppressants market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the immunosuppressants market during the forecast period.

Product Insights and News

• Bms.com - The company offers immunosuppressants named ZEPOSIA, an oral medication taken once daily that offers RMS patients an initiation with no genetic test and no label-based first-dose observation required for patients.
• Roche.com - The company offers immunosuppressants named Elecsys which are essential to prevent acute rejection and ensure the long-term survival of both the patient and the allograft.
• Gsk.com - The company offers immunosuppressants named Benlysta which is used for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The immunosuppressants market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Which are the Key Regions for Immunosuppressants Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the immunosuppressants market in North America. Market growth in this region will be slower than the growth of the market in Asia and Europe.

A rise in the number of organ transplants and technological advancement in the healthcare sector coupled with massive investment in research and development will facilitate the immunosuppressants market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The COVID-19 pandemic in 2020 had a negative impact on the regional market. However, in 2021, the demand for these products rebounded as manufacturing activities resumed due to COVID-19 vaccination drives. These factors will thus drive the growth of the regional immunosuppressants market growth during the forecast period.

What are the Revenue-generating Drug Class Segments in the Immunosuppressants Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The immunosuppressants market share growth by the corticosteroids segment will be significant during the forecast period. Corticosteroids are used as a first-line treatment of autoimmune hemolytic anemia. Patients with autoimmune hemolytic anemia are mostly treated with low doses of corticosteroids. Patients receiving low doses of corticosteroids for more than six months have a lower incidence of relapse. Hence, the increasing prevalence of autoimmune diseases across the globe is expected to increase the demand for corticosteroids and, thereby, contribute to the growth of the market in focus during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the immunosuppressants market size and actionable market insights on the post-COVID-19 impact on each segment.

Immunosuppressants Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the immunosuppressants market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

You may be interested in:

Organ Transplant Immunosuppressant market - Market share will grow at a CAGR of close to 4% during 2017-2021???.

Immunosuppressants Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 7.73%
Market growth 2022-2026	$ 6.99 billion
Market structure	Concentrated
YoY growth (%)	5.3
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Immunosuppressants Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive immunosuppressants market growth during the next five years
• Precise estimation of the immunosuppressants market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the immunosuppressants industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of immunosuppressants market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch